These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16247477

  • 1. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
    Tanaka Y, Kanai F, Ichimura T, Tateishi K, Asaoka Y, Guleng B, Jazag A, Ohta M, Imamura J, Ikenoue T, Ijichi H, Kawabe T, Isobe T, Omata M.
    Oncogene; 2006 Jan 26; 25(4):633-42. PubMed ID: 16247477
    [Abstract] [Full Text] [Related]

  • 2. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.
    Wang H, Sun X, Luo Y, Lin Z, Wu J.
    FEBS Lett; 2006 Oct 30; 580(25):6015-21. PubMed ID: 17052710
    [Abstract] [Full Text] [Related]

  • 3. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.
    Claret FX, Hibi M, Dhut S, Toda T, Karin M.
    Nature; 1996 Oct 03; 383(6599):453-7. PubMed ID: 8837781
    [Abstract] [Full Text] [Related]

  • 4. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
    Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J.
    Nature; 2000 Nov 09; 408(6809):211-6. PubMed ID: 11089976
    [Abstract] [Full Text] [Related]

  • 5. Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis.
    Tanaka Y, Kanai F, Kawakami T, Tateishi K, Ijichi H, Kawabe T, Arakawa Y, Kawakami T, Nishimura T, Shirakata Y, Koike K, Omata M.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):461-9. PubMed ID: 15120623
    [Abstract] [Full Text] [Related]

  • 6. Hepatopoietin interacts directly with COP9 signalosome and regulates AP-1 activity.
    Wang Y, Lu C, Wei H, Wang N, Chen X, Zhang L, Zhai Y, Zhu Y, Lu Y, He F.
    FEBS Lett; 2004 Aug 13; 572(1-3):85-91. PubMed ID: 15304329
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC.
    Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980
    [Abstract] [Full Text] [Related]

  • 9. Jab1 regulates levels of endothelin type A and B receptors by promoting ubiquitination and degradation.
    Nishimoto A, Lu L, Hayashi M, Nishiya T, Horinouchi T, Miwa S.
    Biochem Biophys Res Commun; 2010 Jan 22; 391(4):1616-22. PubMed ID: 20034471
    [Abstract] [Full Text] [Related]

  • 10. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS.
    Oncogene; 2004 Nov 25; 23(55):8868-75. PubMed ID: 15480426
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway.
    Lu C, Li Y, Zhao Y, Xing G, Tang F, Wang Q, Sun Y, Wei H, Yang X, Wu C, Chen J, Guan KL, Zhang C, Chen H, He F.
    FASEB J; 2002 Jan 25; 16(1):90-2. PubMed ID: 11709497
    [Abstract] [Full Text] [Related]

  • 13. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
    Burger-Kentischer A, Finkelmeier D, Thiele M, Schmucker J, Geiger G, Tovar GE, Bernhagen J.
    FEBS Lett; 2005 Mar 14; 579(7):1693-701. PubMed ID: 15757663
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
    Kim JH, Choi JK, Cinghu S, Jang JW, Lee YS, Li YH, Goh YM, Chi XZ, Lee KS, Wee H, Bae SC.
    J Cell Biochem; 2009 Jun 01; 107(3):557-65. PubMed ID: 19350572
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of the hepatitis B virus protein HBx with the human transcription regulatory protein p120E4F in vitro.
    Rui E, Moura PR, Gonçalves KA, Rooney RJ, Kobarg J.
    Virus Res; 2006 Jan 01; 115(1):31-42. PubMed ID: 16112766
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
    Kekulé AS, Lauer U, Weiss L, Luber B, Hofschneider PH.
    Nature; 1993 Feb 25; 361(6414):742-5. PubMed ID: 8441471
    [Abstract] [Full Text] [Related]

  • 19. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.
    Lee CC, Chen SC, Tsai SC, Wang BW, Liu YC, Lee HM, Shyu KG.
    J Biomed Sci; 2006 Jan 25; 13(1):143-56. PubMed ID: 16328781
    [Abstract] [Full Text] [Related]

  • 20. Helioxanthin inhibits interleukin-1 beta-induced MIP-1 beta production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 beta promoter in Huh7 cells.
    Tseng PC, Hsu HC, Janmanchi D, Lin CH, Kuo YH, Chou CK, Yeh SF.
    Biochem Pharmacol; 2008 Oct 30; 76(9):1121-33. PubMed ID: 18789903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.